Brevan Howard Capital Management’s Lyra Therapeutics LYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-281
Closed -$87.3K 1206
2024
Q1
$87.3K Buy
+281
New +$87.3K ﹤0.01% 855